Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene

Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Hachisuka, Junichi, Doi, Kazuko, Moroi, Yoichi, Furue, Masutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: June 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130494/
https://www.ncbi.nlm.nih.gov/pubmed/21743808
http://dx.doi.org/10.1159/000329914
_version_ 1782207618333278208
author Hachisuka, Junichi
Doi, Kazuko
Moroi, Yoichi
Furue, Masutaka
author_facet Hachisuka, Junichi
Doi, Kazuko
Moroi, Yoichi
Furue, Masutaka
author_sort Hachisuka, Junichi
collection PubMed
description Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.
format Online
Article
Text
id pubmed-3130494
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-31304942011-07-08 Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene Hachisuka, Junichi Doi, Kazuko Moroi, Yoichi Furue, Masutaka Case Rep Dermatol Published: June 2011 Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene. S. Karger AG 2011-06-30 /pmc/articles/PMC3130494/ /pubmed/21743808 http://dx.doi.org/10.1159/000329914 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: June 2011
Hachisuka, Junichi
Doi, Kazuko
Moroi, Yoichi
Furue, Masutaka
Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
title Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
title_full Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
title_fullStr Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
title_full_unstemmed Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
title_short Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
title_sort successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene
topic Published: June 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130494/
https://www.ncbi.nlm.nih.gov/pubmed/21743808
http://dx.doi.org/10.1159/000329914
work_keys_str_mv AT hachisukajunichi successfultreatmentofepidermalgrowthfactorreceptorinhibitorinducedperiungualinflammationwithadapalene
AT doikazuko successfultreatmentofepidermalgrowthfactorreceptorinhibitorinducedperiungualinflammationwithadapalene
AT moroiyoichi successfultreatmentofepidermalgrowthfactorreceptorinhibitorinducedperiungualinflammationwithadapalene
AT furuemasutaka successfultreatmentofepidermalgrowthfactorreceptorinhibitorinducedperiungualinflammationwithadapalene

Ejemplares similares